• Butterfly Network has recently begun commercial sales of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile app in Brazil through authorized distributors, bringing its ultrasound-on-chip technology into Latin America’s largest medical device and rapidly expanding ultrasound market.
• This launch not only broadens Butterfly’s international footprint but also targets both high-volume urban hospitals and remote rural communities, potentially reshaping access to diagnostic imaging across Brazil’s public healthcare system.
• We’ll now examine how Butterfly’s entry into Brazil’s large ultrasound market could influence its investment narrative built around AI-driven, recurring revenue growth.

Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

Butterfly Network Investment Narrative Recap

To own Butterfly Network, you need to believe its AI-enabled, handheld ultrasound platform can convert global clinical adoption into durable, high-margin software and licensing revenue despite current losses. The Brazil launch supports the short term catalyst of expanding international device and data volume, but it does not materially reduce the biggest near term risk around execution in new markets and reliance on external healthcare and funding cycles.

Among recent news, the licensing deal with Midjourney Medical stands out next to the Brazil rollout. While Brazil can add devices and data, Midjourney’s up to US$74 million over five years directly relates to Butterfly’s effort to shift its mix toward platform and IP income, which is central to the recurring revenue and AI narrative investors are watching.

Yet beneath the excitement around Brazil and AI, investors should also be aware of the risk that persistent cash burn and potential future dilution could...

Butterfly Network's narrative projects $238.3 million revenue and $7.3 million earnings by 2029. This requires 32.3% yearly revenue growth and an $83.1 million earnings increase from -$75.8 million today.

Uncover how Butterfly Network's forecasts yield a $7.06 fair value, a 7% downside to its current price.

Exploring Other Perspectives

Before Brazil, the most pessimistic analysts were modeling about 15.8% annual revenue growth and no profits within three years, so compared with the consensus catalyst of faster international expansion, they saw delayed deals and weak software mix as powerful headwinds that could still reshape how you think about this stock.

Explore 6 other fair value estimates on Butterfly Network - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Butterfly Network research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Butterfly Network research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Butterfly Network's overall financial health at a glance.

Contemplating Other Strategies?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The latest GPUs need a type of rare earth metal called Neodymium and there are only 31 companies in the world exploring or producing it. Find the list for free.
• Find 45 companies with promising cash flow potential yet trading below their fair value.
• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.